Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection

Journal of Nuclear Medicine

Volumn 55, Issue 9, 2014, Pages 1506-1512

  Witney, Timothy H ^a   Pisaneschi, Federica ^a   Alam, Israt S ^a   Trousil, Sebastian ^a   Kaliszczak, Maciej ^a   Twyman, Frazer ^a   Brickute, Diana ^a   Nguyen, Quang Dé ^a   Schug, Zachary ^b   Gottlieb, Eyal ^b   Aboagye, Eric O ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

FDG; FPIA; Lipid metabolism; PET; Tumor detection

Indexed keywords

CARBOXYLIC ACID; FATTY ACID; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; LIPID; PIVALIC ACID; TRACER; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT; VALERIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CANCER DIAGNOSIS; CELL METABOLISM; CONTROLLED STUDY; FATTY ACID OXIDATION; FEMALE; GLIOMA; HYDROLYSIS; IN VIVO STUDY; KIDNEY CORTEX; LIPID METABOLISM; MOUSE; NONHUMAN; PROSTATE CANCER; TUMOR CELL; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; URINARY EXCRETION; ANIMAL; EXPERIMENTAL NEOPLASM; FDG; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; PET; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TUMOR CELL LINE; TUMOR DETECTION;

FDG; FPIA; LIPID METABOLISM; PET; TUMOR DETECTION;

ANIMALS; CELL LINE, TUMOR; FLUORINE RADIOISOTOPES; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; PENTANOIC ACIDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84907014883     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.140343     Document Type: Article

References (26)

1. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85-95.
2. Baenke F, Peck B, Miess H, Schulze A. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech. 2013;6:1353-1363.
3. Oyama N, Akino H, Kanamaru H, et al. 11C-acetate PET imaging of prostate cancer. J Nucl Med. 2002;43:181-186.
4. Ponde DE, Dence CS, Oyama N, et al. 18F-fluoroacetate: a potential acetate analog for prostate tumor imaging - in vivo evaluation of 18F-fluoroacetate versus 11C-acetate. J Nucl Med. 2007;48:420-428.
5. Witney TH, Alam IS, Turton DR, et al. Evaluation of deuterated F-18- and C-11- labeled choline analogs for cancer detection by positron emission tomography. Clin Cancer Res. 2012;18:1063-1072.
6. Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13:227-232.
7. Bastiaansen JA, Cheng T, Mishkovsky M, Duarte JM, Comment A, Gruetter R. In vivo enzymatic activity of acetylCoA synthetase in skeletal muscle revealed by 13C turnover from hyperpolarized [1-13C]acetate to [1-13C]acetylcarnitine. Biochim Biophys Acta. 2013;1830:4171-4178.
8. Diep QN, Brors O, Bohmer T. Formation of pivaloylcarnitine in isolated rat heart cells. Biochim Biophys Acta. 1995;1259:161-165.
9. Ruff LJ, Brass EP. Metabolic effects of pivalate in isolated rat hepatocytes. Toxicol Appl Pharmacol. 1991;110:295-302.
10. Brass EP. Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol Rev. 2002;54:589-598.
11. Pisaneschi F, Witney TH, Iddon L, Aboagye EO. Synthesis of [F-18]fluoropivalic acid: an improved PET imaging probe for the fatty acid synthesis pathway in tumours. Medchemcomm. 2013;4:1350-1353.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
13. Workman P, Aboagye EO, Balkwill F, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102:1555-1577.
14. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 1989;24:148-154.
15. Witney TH, Carroll L, Alam IS, et al. A novel radiotracer to image glycogen metabolism in tumors by positron emission tomography. Cancer Res. 2014;74: 1319-1328.
16. Smith G, Zhao Y, Leyton J, et al. Radiosynthesis and pre-clinical evaluation of [18F]fluoro-[1,2-2H4]choline. Nucl Med Biol. 2011;38:39-51.
17. Herrmann K, Dahlbom M, Nathanson D, et al. Evaluation of the Genisys4, a bench-top preclinical PET scanner. J Nucl Med. 2013;54:1162-1167.
18. O'Neill LA, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013;493:346-355.
19. Jensen PR, Peitersen T, Karlsson M, et al. Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo. J Biol Chem. 2009;284:36077-36082.
20. Bieber LL. Carnitine. Annu Rev Biochem. 1988;57:261-283.
21. Todesco L, Bodmer M, Vonwil K, Haussinger D, Krahenbuhl S. Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2. Chem Biol Interact. 2009;180:472-477.
22. Holme E, Greter J, Jacobson CE, et al. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet. 1989;2:469-473.
23. Brass EP, Hoppel CL. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem J. 1980;190:495-504.
24. Ullrich KJ, Rumrich G, Kloss S. Reabsorption of monocarboxylic acids in the proximal tubule of the rat-kidney. 1. Transport kinetics of D-lactate, Na1-dependence, pH-dependence and effect of inhibitors. Pflug Arch. 1982;395:212-219.
25. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 2004;1033:30-41.
26. Eaton S, Fukumoto K, Stefanutti G, Spitz L, Zammit VA, Pierro A. Myocardial carnitine palmitoyltransferase I as a target for oxidative modification in inflammation and sepsis. Biochem Soc Trans. 2003;31:1133-1136.